{"id":48432,"date":"2020-06-29T16:05:16","date_gmt":"2020-06-29T13:05:16","guid":{"rendered":"http:\/\/infois.ro\/?p=48432"},"modified":"2020-06-29T16:05:16","modified_gmt":"2020-06-29T13:05:16","slug":"o-noua-terapie-tintita-disponibila-pentru-pacientii-cu-o-forma-rara-de-cancer-pulmonar","status":"publish","type":"post","link":"http:\/\/infois.ro\/?p=48432","title":{"rendered":"O nou\u0103 terapie \u021bintit\u0103, disponibil\u0103 pentru pacien\u021bii cu o forma rar\u0103 de cancer pulmonar"},"content":{"rendered":"<p><a href=\"http:\/\/infois.ro\/wp-content\/uploads\/2020\/06\/radiografie.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft  wp-image-48433\" src=\"http:\/\/infois.ro\/wp-content\/uploads\/2020\/06\/radiografie.jpg\" alt=\"\" width=\"340\" height=\"226\" srcset=\"http:\/\/infois.ro\/wp-content\/uploads\/2020\/06\/radiografie.jpg 640w, http:\/\/infois.ro\/wp-content\/uploads\/2020\/06\/radiografie-300x200.jpg 300w\" sizes=\"(max-width: 340px) 100vw, 340px\" \/><\/a><\/p>\n<p style=\"text-align: justify;\">Pacien\u021bii din Rom\u00e2nia care sufer\u0103 de o form\u0103 mai rar \u00eent\u00e2lnit\u0103 de cancer, cancer pulmonar f\u0103r\u0103 celule mici (CPNMC) ALK-pozitiv (kinaza limfomului anaplazic) au acum acces la tratament cu o terapie \u021bintit\u0103 produs\u0103 de compania Roche. Medicamentul este disponibil pentru pacien\u021bi \u00eencep\u00e2nd cu luna iunie \u0219i este compensat integral prin intermediul Programului Na\u021bional de Oncologie. \u00a0Aproximativ 85% dintre cazurile de cancer pulmonar sunt de tipul cancer pulmonar f\u0103r\u0103 celule mici, iar dintre acestea circa 5% sunt din categoria ALK-pozitiv (kinaza limfomului anaplazic). Acest tip de cancer este cauzat de o fuziune a unei gene sau o rearanjare a acesteia, care provoac\u0103 supraexprimarea proteinei ALK, ceea ce accelereaz\u0103 cre\u015fterea celulelor tumorale. Pacien\u0163ii afecta\u0163i de acest tip de cancer pulmonar sunt mai degrab\u0103 atipici pentru categoriile de risc ale cancerului pulmonar. Aproximativ jum\u0103tate dintre persoanele diagnosticate cu aceast\u0103 form\u0103 au v\u00e2rsta sub 50 de ani \u00een timp ce 70% dintre ace\u0219tia nu sunt fum\u0103tori. \u201eCancerul bronhopulmonar reprezint\u0103 o important\u0103 problem\u0103 de s\u0103n\u0103tate public\u0103 \u00een toat\u0103 lumea, deoarece frecvent este diagnosticat \u00een stadii avansate, mai ales \u00een \u021bara noastr\u0103 ca urmare a lipsei screeningului pentru aceast\u0103 afec\u021biune. Fumatul este unul din factorii ce determin\u0103 apari\u021bia acestei boli dar a fost raportat\u0103 o cre\u0219tere a inciden\u021bei cancerului pulmonar non microcelular, \u00een special adenocarcinom, la nefum\u0103tori sau la fum\u0103torii ocazionali. Acest nou tratament, destinat pacien\u021bilor cu neoplasm pulmonar non-microcelular ce prezint\u0103 fuziunea genei ALK, ofer\u0103 acestora o supravie\u021buire mai \u00eendelungat\u0103 f\u0103r\u0103 semne de boal\u0103 \u0219i reduce riscul apari\u021biei metastazelor cerebrale.\u201d, a declarat Polixenia Iorga, Medic primar Oncologie Medical\u0103, Spitalul Universitar de Urgen\u021b\u0103 Bucure\u0219ti. Terapia este aprobat\u0103 \u00een 88 de \u021b\u0103ri, ca tratament de prim\u0103 linie, cu administrare oral\u0103, pentru persoanele cu cancer pulmonar f\u0103r\u0103 celule mici cu fuziunea genei ALK pozitiv\u0103, \u00een stadiu avansat, inclusiv \u00een Statele Unite, Europa, Japonia \u0219i China. \u00cen Rom\u00e2nia, se estimeaz\u0103 c\u0103 aproximativ 136 de pacien\u021bi ar suferi de aceast\u0103 form\u0103 de cancer pulmonar.<\/p>\n<p style=\"text-align: justify;\">\n","protected":false},"excerpt":{"rendered":"<p>Pacien\u021bii din Rom\u00e2nia care sufer\u0103 de o form\u0103 mai rar \u00eent\u00e2lnit\u0103 de cancer, cancer pulmonar&#8230; <a class=\"meta-more\" href=\"http:\/\/infois.ro\/?p=48432\">more <span class=\"meta-nav\">&raquo;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":48433,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[41,24],"tags":[74,1761,40,3075],"aioseo_notices":[],"_links":{"self":[{"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/posts\/48432"}],"collection":[{"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/infois.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=48432"}],"version-history":[{"count":1,"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/posts\/48432\/revisions"}],"predecessor-version":[{"id":48434,"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/posts\/48432\/revisions\/48434"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/infois.ro\/index.php?rest_route=\/wp\/v2\/media\/48433"}],"wp:attachment":[{"href":"http:\/\/infois.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=48432"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/infois.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=48432"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/infois.ro\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=48432"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}